Small-Molecule Drug Candidate Manufacturers, Suppliers & Companies
-
Manufacturerbased in San Diego, CALIFORNIA (USA)
At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on ...
-
Manufacturerbased in Durham (RTP), NORTH CAROLINA (USA)
Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 ...
Jericho - Therapeutic Drug for Feline Immunodeficiency Virus (FIV)
Jericho is developing a new therapeutic drug for FIV infection in cats, working toward a New Animal Drug Application (NADA) with the FDA. Our ongoing studies indicate that Jericho’s small ...
CONTACT SUPPLIER -
Technologybased in Daejeon, SOUTH KOREA
We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...
DEARGEN - Model Dr. UG - Deep Learning Technology
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN ...
CONTACT SUPPLIER -
Manufacturerbased in Tübingen, GERMANY
Acousia is committed to identifying and developing novel compounds (small molecules) to preserve and enhance natural hearing for patients suffering from sensorineural hearing loss (SNHL), which make up over 90 percent of those affected by hearing ...
Acousia - Model ACOU085 - Small Molecule Drug for Hearing Loss
With its first clinical study underway, Acousia is taking significant strides towards achieving its goal of developing novel medicines that enhance and preserve natural hearing for patients with ...
CONTACT SUPPLIER -
Manufacturerbased in Carlsbad, CALIFORNIA (USA)
Qualigen is a biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack diagnostic platform. The FastPack line of FDA-cleared and ...
Model QN-302 - G4 Binders As Potent Selective Transcription Inhibitors
Qualigen licensed the G4 selective transcription inhibitor platform from University College London (UCL) in 2022. The licensed technology comprises lead compound QN-302 (formerly SOP1812) and back-up compounds that target regulatory regions of ...
CONTACT SUPPLIER -
Manufacturerbased in Muttenz, SWITZERLAND
Krieger established 1947, represents over 70 years of experience and know how in the field of liquids and semi-solids processing. Our technology has made its way into many complete mixing & homogenising systems built to meet both individual customer ...
Krieger - Micro Mixer
With a starting minimum volume of 25 ml, the Micro Mixer range is the ideal tool to scale down your contained mixing processes under pressure or vacuum. Dissolution of expensive shear sensitive API's, proteins, Developing and processing ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you